PCD Pharma Franchise in Rajkot Amzor Healthcare

Elevate your business potential by joining hands with Amzor Healthcare for a PCD Pharma Franchise in Rajkot. With our commitment to quality, innovation, and customer satisfaction, we provide our partners with the necessary support and resources to thrive in the competitive pharmaceutical market.

0 reactions

Regulatory Services in China

Freyr provides End-to-End Regulatory Services in China to pharmaceuticals, Medical Device, Food Supplements, Cosmetic and Consumer Companies to comply with NMPA Regulations. With Regional Delivery Centers, Client Servicing Centers and Offices in USA, UK, EU and India

0 reactions

China cosmetic registration

Get expert guidance on China cosmetic import registration and filing. Ensure compliance with CSAR for both general and special use cosmetics. Freyr is a leading Regulatory solutions provider offering comprehensive services to life sciences firms across the regulatory spectrum.

0 reactions

Food supplements registration China

Get expert support for food supplements registration in China, ensuring full compliance with SAMR regulations and market entry with ease. Contact us today! China Food Supplement Regulation falls under the State Administration for Market Regulation (SAMR). The responsibility is shared between the state, provincial, municipal, and county-level authorities.

0 reactions

China Medical Device Registration

Freyr provides China medical device registration and approval support for device manufacturers that includes registration, classification, NMPA legal agent/representation services for product compliance as per NMPA & CMDE regulations. China is one of the fastest-growing markets for Medical Devices, where the demand for devices is majorly met through imports.

0 reactions

China Drug Registration and Approval

Freyr provides China Drug Registration and Approval support for pharmaceutical manufacturers that includes product classification, registration and approval for regulatory compliance as per NMPA regulations. As the world’s best pharmaceutical manufacturing powerhouse, China offers many business opportunities for pharma manufacturers

0 reactions

China NMPA Registration

Freyr provides End-to-End Regulatory Services in China to pharmaceuticals, Medical Device, Food Supplements, Cosmetic and Consumer Companies to comply with NMPA Regulations. Freyr is a leading Regulatory solutions provider offering comprehensive services to life sciences firms across the regulatory spectrum..

0 reactions

Brazil Drug Registration and Approval

Freyr provides Brazil Drug Registration and Approval support for pharmaceutical manufacturers that includes product classification, registration and approval for regulatory compliance as per ANVISA regulations. In Brazil drug registration and Brazil regulatory drug approval process are governed by a high-quality Regulatory system that constantly updates its standards, driven by the belief that healthcare is a constitutional right.

0 reactions

Brazil Medical Device Registration

Freyr provides Brazil medical device registration and approval support for device manufacturers that include registration, classification, INMETRO certification and Brazil Registration Holder (BRH) services for product compliance as per ANVISA regulations.

0 reactions

Brazil medical device approval

Overview The Life Sciences industry is built on innovation in terms of their constant search for new drugs, devices, and cures. Technology has become ubiquitous in driving not only scientific innovation but also in building, integrating, and managing platforms that support scientific innovation. At Freyr, we understand global Regulatory requirements management and its impact on day-to-day Regulatory decisions in strategy, submission planning, preparation, and dossier creation.

0 reactions

Food Supplements Regulatory Services Brazil

Freyr provides food regulatory services in brazil for food supplements span across product registration, classification, label, claims review, formulation review/ingredient assessment, gap analysis and dossier compilation as per ANVISA regulations for compliant market entry.

0 reactions